APA (7th ed.) Citation

Elizabeth R. Packnett, Isabelle H. Winer, Abiola Oladapo, & Matthew Wojdyla. (2023). Risk of RSV-related hospitalization is associated with gestational age in preterm (born at 29-34 wGA) infants without outpatient palivizumab administration. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Elizabeth R. Packnett, Isabelle H. Winer, Abiola Oladapo, and Matthew Wojdyla. Risk of RSV-related Hospitalization Is Associated with Gestational Age in Preterm (born at 29-34 WGA) Infants Without Outpatient Palivizumab Administration. Taylor & Francis Group, 2023.

MLA (9th ed.) Citation

Elizabeth R. Packnett, et al. Risk of RSV-related Hospitalization Is Associated with Gestational Age in Preterm (born at 29-34 WGA) Infants Without Outpatient Palivizumab Administration. Taylor & Francis Group, 2023.